Joe Rogan Experience #1246 - Pot Debate - Alex Berenson & Dr. Michael Hart

Episode Summary

Main Topics Discussed

• Cannabis as Medicine vs. Recreational Intoxicant: A central debate on whether cannabis, particularly high-THC varieties, should be classified as a medicine or primarily as a recreational drug.
• Risks and Benefits of Cannabis: Discussion on the potential harms (e.g., psychotic breaks, violence, mental illness) and therapeutic benefits (e.g., for glaucoma, cancer, AIDS, autism, epilepsy, PTSD).
• Comparison of Cannabis and Alcohol: Extensive comparison regarding death rates, associated harms (violence, suicide, accidents), and physical toxicity versus neurotoxicity.
• Validity of Evidence: The ongoing tension between anecdotal patient experiences and clinical observations versus the demand for rigorous randomized controlled trials (RCTs).
• Medical Marijuana Laws and Physician Practices: Scrutiny of how medical marijuana is prescribed in the US versus Canada, and the integrity of the medical authorization process.
• Distinction between THC and CBD: Emphasizing the different psychoactive and therapeutic properties of the main cannabinoids.

Key Insights & Memorable Moments

• Joe Rogan, despite his known advocacy for marijuana, expresses concerns about its universal safety, citing instances of prolonged highs from edibles and the variability of its effects on individuals.
• Alex Berenson highlights his frustration with other media platforms (e.g., Bill Maher, NPR) that allegedly refused to host him to discuss his critical book, "Tell Your Children," applauding Rogan for enabling the debate.
• A heated exchange occurs regarding the methodology of counting drug-related deaths; Berenson argues that if cannabis-associated deaths (e.g., suicides, violence with THC in blood) were accounted for like alcohol-associated deaths, the number would be significantly higher than zero.
• Dr. Hart emphasizes the clear distinction between psychoactive THC and non-psychoactive CBD, stressing that many of his medical patients in Canada specifically seek CBD and do not want to get high.
• Berenson asserts that scientific randomized controlled trials have "almost unequivocally shown that cannabis doesn't work as a medicine" for most conditions, leading to strong rebuttals from Dr. Hart who cites specific cancer research, PTSD studies, and flaws in Berenson's cited pain studies.
• Dr. Hart provides a clinician's perspective, explaining how he uses cannabis (including Nabilone, a pure THC drug) to address deficiencies like low anandamide levels in PTSD patients, arguing that correcting such imbalances is fundamentally medical.
• A direct challenge is made by Dr. Hart to Berenson's interpretation of the National Academies of Science and Engineering report, citing a committee member who stated the report did not conclude cannabis causes schizophrenia.

Notable Quotes or Revelations

• Alex Berenson: "I don't think marijuana is medicine. It has a few medical uses... But for the most part, people use THC and cannabis as recreational intoxicants... I don't think if you look sort of on a population level basis they're less than alcohol."
• Dr. Michael Hart: "When we're looking at cannabis there's zero deaths attributed to the use of cannabis itself... just based upon that alone it makes it much much safer than alcohol."
• Alex Berenson: "If and when we do this number for cannabis... the number's gonna be a lot higher than zero. I suspect it will be in the 10 to 20,000 range." (Referring to cannabis-associated deaths)
• Dr. Michael Hart: "Almost all my patients as soon as they come in they say, 'I don't want to get high, I don't want to get high.' Like that's almost what everyone says."
• Joe Rogan: "CBD has been shown to reduce seizures in children with epilepsy. It's... okay, they may be anecdotal, but I have a good friend who has a child who he uses it on and he showed it mean it's been a game-changer."
• Alex Berenson: "When those trials have been done... they've almost unequivocally shown that cannabis doesn't work as a medicine."
• Dr. Michael Hart (citing Ziva Cooper, NAS Committee Member): "She says in response to the recent New York Times editorial on cannabis... we did not conclude that cannabis causes schizophrenia."

Overall Themes

• The Nuance of Cannabis: The podcast highlights that "cannabis" is not a monolithic substance, with critical distinctions between high-THC products, CBD, and other cannabinoids influencing its effects, risks, and benefits.
• Evidence vs. Experience: A core tension exists between the demand for gold-standard scientific evidence (randomized controlled trials) emphasized by Berenson, and the value of clinical experience, epidemiological data, and patient-reported outcomes championed by Dr. Hart.
• Public Perception and Policy: The debate underscores how the narrative around cannabis (as medicine, as intoxicant, or as a gateway to legalization) shapes public understanding, medical practice, and regulatory approaches.
• Risk Assessment and Harm Reduction: While both guests acknowledge potential risks, they differ significantly on the magnitude of these risks compared to other substances, particularly alcohol, prompting a discussion on how best to understand and mitigate harms.